These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32379519)

  • 1. Anti-CD44 DNA Aptamers Selectively Target Cancer Cells.
    Pęcak A; Skalniak Ł; Pels K; Książek M; Madej M; Krzemień D; Malicki S; Władyka B; Dubin A; Holak TA; Dubin G
    Nucleic Acid Ther; 2020 Oct; 30(5):289-298. PubMed ID: 32379519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.
    Somasunderam A; Thiviyanathan V; Tanaka T; Li X; Neerathilingam M; Lokesh GL; Mann A; Peng Y; Ferrari M; Klostergaard J; Gorenstein DG
    Biochemistry; 2010 Oct; 49(42):9106-12. PubMed ID: 20843027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
    Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
    PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer.
    Koltai T; Reshkin SJ; Carvalho TMA; Cardone RA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.
    Roy R; Mandal S; Chakrabarti J; Saha P; Panda CK
    Mol Cell Biochem; 2021 Oct; 476(10):3701-3709. PubMed ID: 34081254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
    BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance.
    Xu Z
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2849-2876. PubMed ID: 37991544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular weight of surface immobilized hyaluronic acid influences CD44-mediated binding of gastric cancer cells.
    Amorim S; da Costa DS; Freitas D; Reis CA; Reis RL; Pashkuleva I; Pires RA
    Sci Rep; 2018 Oct; 8(1):16058. PubMed ID: 30375477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
    Birzele F; Voss E; Nopora A; Honold K; Heil F; Lohmann S; Verheul H; Le Tourneau C; Delord JP; van Herpen C; Mahalingam D; Coveler AL; Meresse V; Weigand S; Runza V; Cannarile M
    Clin Cancer Res; 2015 Jun; 21(12):2753-62. PubMed ID: 25762343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
    Bourguignon LY; Singleton PA; Zhu H; Zhou B
    J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.
    Lo CW; Chan CKW; Yu J; He M; Choi CHJ; Lau JYW; Wong N
    Nanotheranostics; 2022; 6(2):161-174. PubMed ID: 34976591
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.